Àå±â Ĩ(Organ-on-a-Chip) ½ÃÀå ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Organ-on-a-Chip Market Size, Share & Trends Analysis Report By Products & Service (Products, Service), By Application (Drug Discovery, Toxicology Research), By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1587816
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àå±â Ĩ ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è Àå±â Ĩ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 9¾ï 5,240¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº 2025-2030³â±îÁö 35.11%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ½Å¾à °³¹ß ¼ö¿ä Áõ°¡, ¹Î°£ ¹× °ø°ø ±â¾÷ÀÇ ÅõÀÚ ¹× ÀÚ±Ý Á¶´Þ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ÇÐ°è ¹× ¿¬±¸±â°üÀÇ ¼ö¿ä Áõ°¡·Î ÀÎÇÑ ½ÃÀå °æÀï ½ÉÈ­µµ ¿¹Ãø ±â°£ µ¿¾È »ê¾÷ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, È¿À²ÀûÀÎ ½Å¾à°³¹ß ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ƯÈ÷ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù NETRI´Â Axion BioSystems¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î°í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Á¦Ç°±º Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¦Ç° ¶óÀÎÀº AxionÀÇ Maestro MultiElectrode Array(MEA) ½Ã½ºÅÛ°ú ȣȯµÇ¸ç Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÃþÀ» °®Ãá µ¶Æ¯ÇÑ ±¸È¹Çü ¹Ì¼¼À¯Ã¼ ±â±â¸¦ ¼Ò°³ÇÕ´Ï´Ù. Áï½Ã »ç¿ë °¡´ÉÇÑ ÀÌ Ç÷§ÆûÀº Àå±â Ĩ ¾ÖÇø®ÄÉÀ̼ÇÀ» À§ÇÑ °í󸮷® ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ½Å°æÇÐ, ÇǺΰúÇÐ, Áúº´ ¿¬±¸ ¹× ½Å¾à°³¹ß¿¡ Áß¿äÇÑ ±âŸ ºÐ¾ßÀÇ Ã·´Ü ¿¬±¸¸¦ ÃËÁøÇÕ´Ï´Ù.

¶ÇÇÑ, °£ ¿ÂĨ ºÎ¹®Àº »ý¹° ÀÇÇÐ ¿¬±¸¿Í ÀǾàǰ °³¹ßÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ Àå±â Ĩ »ê¾÷ÀÇ Áß¿äÇÑ °ßÀÎÂ÷ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 9¿ù, Àå±â Ĩ »ê¾÷ÀÇ ÁÖ¿ä ÁøÀÔÀÚÀÎ CN Bio´Â Àü Àΰ£ ¿¬±¸ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Àü¹®¼ºÀ» ¼¼°èÀûÀ¸·Î ÀÎÁ¤¹Þ°í ÀÖ´Â ºñ¿µ¸® ´ÜüÀÎ LifeNet Health LifeSciences¿Í Á¦ÈÞÇß½À´Ï´Ù. À̹ø Á¦ÈÞ´Â CN¹ÙÀÌ¿ÀÀÇ ÇÇÁö¿À¹Í½º OOC ½Ã¸®Áî¿¡ LifeNet HealthÀÇ °ËÁõµÈ 1Â÷ Àΰ£ ¼¼Æ÷¸¦ °ø±ÞÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. À̹ø °è¾à¿¡¼­ LifeNet Health´Â CN BioÀÇ ºñ¾ËÄڿüº Áö¹æ°£¿°(NASH) 'in-a-box' ŰƮ¸¦ ÅëÇØ ¶Ç´Â LifeNet Health¿¡¼­ Á÷Á¢ °ø±Þ¹ÞÀ» ¼ö ÀÖ´Â ÃÖ°í ǰÁúÀÇ MPS °ËÁõ °£¼¼Æ÷¸¦ Á¦°øÇϱâ·Î Çß½À´Ï´Ù.

¶ÇÇÑ, ºÏ¹Ì´Â 2023³â Àå±â Ĩ »ê¾÷À» Áö¹èÇÏ°í ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ÀÌ Áö¿ªÀÇ ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç¿Í Á¤ºÎÀÇ ³ë·ÂÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù ¹ÙÀÌ¿¤(Bayer AG)Àº esqLABS ¹× Dynamic42¿Í Á¦ÈÞÇß½À´Ï´Ù. À̵éÀº ÀÇ·á »ê¾÷¿¡¼­ ÀǾàǰ °³¹ßÀ» À§ÇÑ µ¿¹° ½ÇÇèÀ» ÁÙÀ̱â À§ÇØ 1³â°£ÀÇ Àå±â Ĩ ÆÄÀÏ·µ ÇÁ·Î±×·¥À» µµÀÔÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ºñÁî´Ï½º ÀÌ´Ï¼ÅÆ¼ºê´Â ºÏ¹ÌÀÇ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àå±â Ĩ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå Á¦Ç°¡¤¼­ºñ½º ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

Á¦7Àå Á¦Ç°¡¤¼­ºñ½º, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° Áö¿ª ºñÁî´Ï½º ºÐ¼®

Á¦8Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Organ-on-a-chip Market Growth & Trends:

The global organ-on-a-chip market size is anticipated to reach USD 952.4 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to register a CAGR of 35.11% from 2025 to 2030. Factors such as the increasing prevalence of chronic disease, the rising need for drug discovery, and growing investment and funding from private and public players are expected to drive the market growth. In addition, increasing competition in the market owing to rising demand from pharmaceutical & biotechnology companies and academic & research institutions is also anticipated to propel the industry growth over the forecast period.

Moreover, the increasing demand for efficient drug discovery techniques, particularly in the context of the rising prevalence of chronic diseases is driving the market growth. For instance, in July 2023, NETRI, in partnership with Axion BioSystems, announced the launch of the NeuroFluidics MEA line. This product line, compatible with Axion's Maestro MultiElectrode Array (MEA) systems, introduces a unique range of compartmentalized microfluidic instruments with an MEA layer. These ready-to-use platforms offer high-throughput solutions for organs-on-chip applications, facilitating advanced research in neurology, dermatology, and other fields crucial for disease study and drug discovery.

Moreover, the liver-on-a-chip segment is a significant driver of the organ-on-a-chip industry, driven by its key role in advancing biomedical research and drug development. For instance, in September 2023, CN Bio, a key player in the organ-on-a-chip industry, collaborated with LifeNet Health LifeSciences, a nonprofit organization recognized globally for its expertise in all-human research solutions. The collaboration aims to supply CN Bio's PhysioMimix OOC range with validated primary human cells from LifeNet Health. In this agreement, LifeNet Health provided supreme-quality, MPS-validated hepatic cells that can be accessed through CN Bio's 'in-a-box' kit for Non-Alcoholic Steatohepatitis (NASH), or directly from LifeNet Health.

Furthermore, North America dominated the organ-on-a-chip industry in 2023 and is projected to grow at the fastest CAGR over the forecast period. The growth is attributed to the presence of key market players in the region and government initiatives. For instance, in March 2023, Bayer AG collaborated with esqLABS and Dynamic42. They introduced a one-year organ-on-a-chip pilot program to reduce testing on animals for drug development in the healthcare industry. Such business initiatives are anticipated to contribute to the growth of the market of the North America region.

Organ-on-a-chip Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Products & Service Group Business Analysis

Chapter 5. Application Group Business Analysis

Chapter 6. End Use Business Analysis

Chapter 7. Regional Business Analysis by Products & Service, Application, End Use

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â